002099.SZ · 海翔药业
China A-shares · RS rating 91 · As of 2026-10-14
| Price | 6.17 CNY |
|---|---|
| 1-day change | +1.0% |
| RS rating (overall / 1M / 3M / 12M) | 91 / 95 / 90 / 70 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 31 / 27 / 28 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +10.2% |
| Distance from 52-week high | +30.1% |
| Market cap (USD) | $1.5B |